Targeting FcRn to Generate Antibody-Based Therapeutics
Year: 2018
Type: review
Authors: E. Sally Ward, Raimund J. Ober
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: green
Funders: Cancer Research Institute, National Multiple Sclerosis Society, Cancer Prevention and Research Institute of Texas, Argenx, National Institute for Health and Care Research, MedImmune, National Institutes of Health, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, National Institute of Arthritis and Musculoskeletal and Skin Diseases
Awards: Mechanistic studies of FcRn inhibitors for the treatment of IgG-mediated diseases, Structure-function studies of human FcRn, G3687784255, Targeting HER2 for Cancer Therapy, High accuracy quantum dot tracking in live cells, Quantitative Aspects of Single Molecule Detection, G5879252039, Targeting HER2 for cancer therapy, Improving contrast for antibody-based tumor detection using PET
OpenAlex ID: W2888528653
